Therapeutic substitution: an option for cost-effective prescribing?
S R
SR
Shulman
W
W
Gouveia
D003362:Cost-Benefit Analysis; D006801:Humans; D010606:Pharmacy and Therapeutics Committee; D013810:Therapeutic Equivalency